Next |
home / stock / adxs / adxs message board
Subject | By | Source | When |
---|---|---|---|
The only safe haven for $$$$ these days | hdwrsft | investorshub | 03/22/2023 5:15:04 PM |
What a turd. CEO Ken is running this | Ryguy008 | investorshub | 03/20/2023 2:35:37 PM |
Another massive bank shockingly failed. One day it's | hdwrsft | investorshub | 03/12/2023 6:03:14 AM |
Just think, in just another 7 years, and | hdwrsft | investorshub | 02/14/2023 2:26:10 PM |
If there is any justice in this universe, | HereToFightScams | investorshub | 01/11/2023 4:23:53 AM |
Looks like things are picking up we may | carp77 | investorshub | 01/09/2023 7:50:00 PM |
Well its certainly been a learning experience. I | James salmon | investorshub | 01/05/2023 9:16:35 PM |
James, Are you as broke as I am | oakrock | investorshub | 01/04/2023 2:19:13 AM |
Hmm (Glancing at the EOY PPS). Some things | hdwrsft | investorshub | 12/27/2022 8:04:25 PM |
Them pesty R/S's pop up quicker than weeds | hdwrsft | investorshub | 12/22/2022 10:40:59 PM |
Waiting patiently for the next 20 for 1 | ADXSINC | investorshub | 12/22/2022 9:47:10 PM |
Crickets. | hdwrsft | investorshub | 12/22/2022 5:04:45 PM |
I see alot of same names (fellow bag | Traderbx | investorshub | 12/17/2022 10:16:01 PM |
The last of someones FTX crypto currency investdonation......? | hdwrsft | investorshub | 12/15/2022 10:20:40 PM |
Salmon man adding? | girlfriend | investorshub | 12/15/2022 10:17:35 PM |
That was blue eyes, she is still buying | ADXSINC | investorshub | 12/15/2022 10:15:16 PM |
Volume posted this early AM: 1 Totally laughable. | hdwrsft | investorshub | 12/15/2022 2:47:46 PM |
Not sure what data you are referring to. | ubmmg | investorshub | 12/13/2022 10:15:07 PM |
Hi Nick, | phytokaiser1 | investorshub | 12/07/2022 10:19:48 PM |
I'm hearing a lot of chatter about psylocybin | Nickwvt | investorshub | 12/07/2022 4:49:27 PM |
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...
International Zeolite Corp. (IZCFF) is expected to report for Q2 2024 International Stem Cell Corporation (ISCO) is expected to report for Q4 2023 Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4...